Thursday, November 7th, 2013
An industry-first campaign, run by Doctors.net.uk to launch a new HRT product, has engaged thousands of doctors and made a significant impact on sales. The campaign for Abbott Established Pharmaceuticals Division (EPD) was the first new product launch to be delivered solely via a digital channel for the pharma industry.
Posted in pharma7 | Comments Off on Ground-breaking product launch proves value of digital
Monday, November 4th, 2013
Back in 2011 when Google+ emerged from Beta and started offering branded pages, there was a good deal of commentary in the blogosphere about the potential use for the new platform by pharma – even here at Eye on FDA. Now, nearly two years later, it seemed like a good time to check in and see what the experience has been.
Posted in pharma7 | Comments Off on Catching Up on Google+ and Pharma
Friday, November 1st, 2013
Diabetes has been around a long time. First documented in an Egyptian papyrus around 1550BC, the condition was described as “too great emptying of the urine”1. In around 30–90 AD the Greek Physician Artaeus noted symptoms such as constant thirst, excessive urination and loss of weight, and coined the name diabetes – “to pass through”2. Some years later (131-201AD), Artaeus’s Roman counterpart Galen recorded the rarity of the condition and hypothesized a link to renal dysfunction.
Posted in pharma7 | Comments Off on Communicating diabetes to the online masses – how can pharma take advantage?
Sunday, October 27th, 2013
Sorry, this entry is only available in Magyar.
Posted in pharma7 | Comments Off on (Magyar) Wikipédia – a gyógyszeripari marketing előtt álló feladat
Friday, October 25th, 2013
“Pharma need to get into a mind-set of developing campaigns based on initial research and understanding, execute on these, measure results, tailor or completely redevelop the approach – and continue execution. And this needs to happen on an on-going basis, on-going experimentation driving towards a ‘continuous plan of action’,” said Jan van den Burg VP, Commercial Strategy at Veeva Europe.
Posted in pharma7 | Comments Off on Encourage a Culture of Experimentation to Perfect Your Multichannel Strategy
Friday, October 25th, 2013
Consumers have long used health websites and other online tools to gather information about conditions and treatments. Now they are broadening their health activity online, using Internet resources to support healthcare decision-making and to manage conditions, a new study shows.
Posted in pharma7 | Comments Off on Digital tools and online health services poised to play key role in consumer health management, study finds
Monday, October 21st, 2013
Crazy monsters, bizarre furniture and weird pets are at the heart of a new mobile game from Sanofi UK for children with diabetes.
Posted in pharma7 | Comments Off on Sanofi launches a monster mobile diabetes game
Thursday, October 17th, 2013
It is a difficult time for pharma facing challenges such as declining R&D and a poor industry reputation. Being such a heavily regulated sector, demands on pharma, in addition to medtech, are steadily increasing. This article explores the current regulatory and legal environment that is shaping European pharma.
Posted in pharma7 | Comments Off on The changing environment for pharma and medtech companies in Europe
Tuesday, October 15th, 2013
The rise of personal blogging has grown in the past decade with millions taking to the internet to tell their stories and share their opinions. In recent years the impact of blogging as a social media strategy has not gone unnoticed by the corporate world, and pharma has been quick to get in on the act.
Posted in pharma7 | Comments Off on Pharma blogs: going beyond the press release?
Friday, October 11th, 2013
Global doctors alliance Networks in Health has partnered with Merqurio to extend its reach into Italy. Set up in 2006 and open to both doctors and pharmacists, Merqurio adds more than 160,000 new doctors to the 2 million-strong Networks in Health membership.
Posted in pharma7 | Comments Off on Networks in Health expands into Italy
You are currently browsing the archives for the pharma7 category.
